SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (10751)3/1/2004 3:34:08 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
And here is a repost of Harold's earlier post on the SEPR thread giving the requirements for Class 1 vs Class 2 resubmissions:

Definitions of Class 1 and Class 2 from fda.gov

D. Class 1 resubmitted applications are applications resubmitted after a complete
response letter (or a not approvable or approvable letter) that include the following
items only (or combinations of these items):
1. Final printed labeling
2. Draft labeling
3. Safety updates submitted in the same format, including tabulations, as the
original safety submission with new data and changes highlighted (except
when large amounts of new information including important new adverse
experiences not previously reported with the product are presented in the
resubmission)
4. Stability updates to support provisional or final dating periods
5. Commitments to perform Phase 4 studies, including proposals for such studies
6. Assay validation data
7. Final release testing on the last 1-2 lots used to support approval
8. A minor reanalysis of data previously submitted to the application (determined
by the agency as fitting the Class 1 category)
9. Other minor clarifying information (determined by the Agency as fitting the
Class 1 category)
10. Other specific items may be added later as the Agency gains experience
with the scheme and will be communicated via guidance documents to
industry.
E. Class 2 resubmissions are resubmissions that include any other items, including any
item that would require presentation to an advisory committee.


Peter